Skip to content

News & calendar

news: as of 2026-10-13
What the marks mean

Importance is a model-assigned 1–5 on published stories, not a market forecast.

Impact on a scheduled row is a company-prominence tier (High/Medium from graph centrality and size; Low only on curated minor events), not a magnitude forecast.

An earnings date marked confirmed is company-confirmed by Yahoo Finance; estimated is not yet announced. Unmarked rows carry no recorded provenance.

Economic releases are macro and carry no industry, so they stay in every view. A release with no value has not printed yet and says so rather than showing a zero.

Upcoming events across the tracked universe; past events are archived, with outcomes added where available — curated and cited, never fabricated. A past row without one reads “outcome pending”.

A lock-up or index change row adds one line of arithmetic — shares becoming sellable, or shares index funds must buy, as a share of float — read off the prospectus or the index methodology, with both numbers cited in the row. It states the mechanics, not a price move. A lock-up date derived as IPO + 180 days stays estimated until the company states it.

Ahead

scheduled · today and tomorrow · calendar refreshed 2026-10-12

Tue · 13 Oct · today

Wed · 14 Oct

Behind

published · newest first

Thu · 9 Jul

personnel

15:08
Google News: Takara Bio

Takara Bio USA, Inc. Announces the Retirement of Carol Lou, Appoints Andrew Farmer as President and CEO

Takara Bio USA announced the retirement of President/CEO Carol Lou and the appointment of Andrew Farmer as her successor.

Markets open original ↗

funding

14:50
Google News: Syensqo

Syensqo Expands Maryland Plant With 30% Capacity Boost

Syensqo is expanding its Havre de Grace, Maryland manufacturing plant, boosting capacity by 30%.

Markets open original ↗

partnership

14:44
Google News: Sumitomo Electric Industries

Sumitomo Electric and Van Oord Consortium Secures HVDC Cable Framework Agreement with SSEN Transmission

Sumitomo Electric and Van Oord's consortium secured a long-term HVDC cable framework agreement with SSEN Transmission.

Markets open original ↗

partnership

14:37
Google News: Teva Pharmaceutical Industries Ltd.

Teva and Samsung Bioepis Enter Commercialization Agreement for OPUVIZ®, a Biosimilar Referencing Eylea®, in Canada

Teva and Samsung Bioepis entered a commercialization agreement for the OPUVIZ biosimilar in Canada.

Markets open original ↗

partnership

14:18
Google News: Centene Corporation

Centene Corporation (CNC) Secures Illinois Medicaid Contract for Meridian Health Plan

Centene secured an Illinois Medicaid contract for its Meridian Health Plan subsidiary.

Markets open original ↗

The wire

everything that arrived · 7 days